Marwa Matboli Sayed

Title: Marwa Matboli Sayed: Innovator in Cardiac Diagnostics

Introduction

Marwa Matboli Sayed is a prominent inventor based in Vienna, VA (US). She has made significant contributions to the field of cardiac diagnostics through her innovative research and inventions. Her work focuses on the early diagnosis of ischemic cardiac events, which is crucial for improving patient outcomes.

Latest Patents

Marwa Matboli Sayed holds a patent for her invention titled "Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients." This invention provides a molecular network, devices, and assays for the early diagnosis of ischemic cardiac events in patients experiencing chest pain. It allows for the differentiation of chest pain due to ischemic cardiac events from other non-cardiac causes. The invention features a Nourin-based RNA molecular network composed of lncRNA-CTB89H12.4, hsa-miRNA-137, and FTLH-17 mRNA, which are linked to cardiovascular ischemia. This innovative approach specifically diagnoses ischemic cardiac events with high accuracy.

Career Highlights

Marwa Matboli Sayed has dedicated her career to advancing medical diagnostics. Her research has led to the development of groundbreaking technologies that enhance the understanding and treatment of cardiac conditions. She is associated with Nour Heart, Inc., where she continues to innovate in the field of cardiac health.

Collaborations

Marwa collaborates with Salwa A Elgebaly, who is also a key contributor to their research efforts. Together, they work on projects that aim to improve diagnostic methods for cardiac patients.

Conclusion

Marwa Matboli Sayed's contributions to cardiac diagnostics through her innovative patent highlight her commitment to improving patient care. Her work exemplifies the impact of research and innovation in the medical field.